YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Kenvue urges FDA to reject autism warning request on Tylenol

Posted online

Tylenol maker Kenvue is urging the Food and Drug Administration to reject labeling changes requested in a citizen petition filed last month.

The Trump administration recently linked the use of acetaminophen products during pregnancy to autism.

However, the proposed labeling changes are not supported by existing science, according to Kenvue.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences